Pacific Biosciences of California, Inc.
(NASDAQ: PACB)

Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States. The Company's single molecule real time (SMRT) technology's combination of performance characteristics is the result of an approach that uses a single DNA polymerase working in a continuous processing manner to synthesize DNA.

2.360 -

-0.020 (-0.84%)
Range 2.300 - 2.420   (5.22%)
Open 2.360
Previous Close 2.380
Bid Price 2.360
Bid Volume 4,063
Ask Price 2.370
Ask Volume 5,790
Volume 6,508,524
Value 11,585,402
Remark -
Delayed prices. Updated at 30 Jan 2026 03:05.
Data powered by
View All Events

About Pacific Biosciences

Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States. The Company's single molecule real time (SMRT) technology's combination of performance characteristics is the result of an approach that uses a single DNA polymerase working in a continuous processing manner to synthesize DNA.

Loading Chart...

Please login to view stock data and analysis